PacificHealth Laboratories Valuation

Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. PacificHealth Laboratories recent Real Value cannot be determined due to lack of data. The prevailing price of PacificHealth Laboratories is $0.0. Our model determines the value of PacificHealth Laboratories from analyzing the company fundamentals such as Return On Equity of -0.75, operating margin of (0.14) %, and Shares Outstanding of 20.87 M as well as examining its technical indicators and probability of bankruptcy.

PacificHealth Laboratories Total Value Analysis

PacificHealth Laboratories is at this time expected to have valuation of 571.89 K with market capitalization of 87, debt of 54.86 K, and cash on hands of 324.48 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PacificHealth Laboratories fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
571.89 K
87
54.86 K
324.48 K

PacificHealth Laboratories Investor Information

The company has price-to-book ratio of 0.71. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PacificHealth Laboratories recorded a loss per share of 0.05. The entity had not issued any dividends in recent years. Based on the key indicators related to PacificHealth Laboratories' liquidity, profitability, solvency, and operating efficiency, PacificHealth Laboratories is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.

PacificHealth Laboratories Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PacificHealth Laboratories has an asset utilization ratio of 365.71 percent. This signifies that the Company is making $3.66 for each dollar of assets. An increasing asset utilization means that PacificHealth Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.

PacificHealth Laboratories Profitability Analysis

The company reported the previous year's revenue of 6.91 M. Net Loss for the year was (486.31 K) with profit before overhead, payroll, taxes, and interest of 2.99 M.

PacificHealth Laboratories Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Retained Earnings-20.1 M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in PacificHealth Pink Sheet

If you are still planning to invest in PacificHealth Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PacificHealth Laboratories' history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamental Analysis
View fundamental data based on most recent published financial statements
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data